BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ward MG, Irving PM, Sparrow MP. How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease? World J Gastroenterol 2015; 21(40): 11331-11342 [PMID: 26525434 DOI: 10.3748/wjg.v21.i40.11331]
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11331.htm
Number Citing Articles
1
Nienke Z. Borren, Grace Conway, William Tan, Elizabeth Andrews, John J. Garber, Vijay Yajnik, Ashwin N. Ananthakrishnan. Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2017; 23(7): 1234 doi: 10.1097/MIB.0000000000001133